Fisetin induces apoptosis through p53-mediated up-regulation of dr5 expression in human renal carcinoma caki cells

Molecules

Volumn 22, Issue 8, 2017, Pages

  Min, Kyoung jin ^a   Nam, Ju Ock ^b   Kwon, Taeg Kyu ^a  

^a Keimyung University   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

Apoptosis; DR5; Fisetin; P53; Renal carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CASPASE INHIBITOR; FISETIN; FLAVONOID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEPTIDE CHLOROMETHYL KETONE; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANIMAL; APOPTOSIS; CARCINOMA; DOWN REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; KIDNEY TUMOR; METABOLISM; MOUSE; TUMOR CELL LINE; UPREGULATION;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA; CASPASE INHIBITORS; CELL LINE, TUMOR; DOWN-REGULATION; FLAVONOIDS; HUMANS; KIDNEY NEOPLASMS; MICE; POLY(ADP-RIBOSE) POLYMERASES; REACTIVE OXYGEN SPECIES; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 85028047225     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules22081285     Document Type: Article

References (33)

1. Syed, D.N.; Adhami, V.M.; Khan, N.; Khan, M.I.; Mukhtar, H. Exploring the molecular targets of dietary flavonoid fisetin in cancer. Semin. Cancer Biol. 2016, 40, 130–140. [CrossRef] [PubMed]
2. Youns, M.; Hegazy, W.A.H. The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways. PLoS ONE 2017, 12, e0169335. [CrossRef] [PubMed]
3. Sabarwal, A.; Agarwal, R.; Singh, R.P. Fisetin inhibits cellular proliferation and induces mitochondria-dependent apoptosis in human gastric cancer cells. Mol. Carcinog. 2017, 56, 499–514. [CrossRef] [PubMed]
4. Kwak, S.; Ku, S.K.; Bae, J.S. Fisetin inhibits high-glucose-induced vascular inflammation in vitro and in vivo. Inflamm. Res. 2014, 63, 779–787. [CrossRef] [PubMed]
5. Seo, S.H.; Jeong, G.S. Fisetin inhibits TNF-alpha-induced inflammatory action and hydrogen peroxide-induced oxidative damage in human keratinocyte HaCaT cells through PI3K/AKT/Nrf-2-mediated heme oxygenase-1 expression. Int. Immunopharmacol. 2015, 29, 246–253. [CrossRef] [PubMed]
6. Kim, N.; Lee, S.H.; Son, J.H.; Lee, J.M.; Kang, M.J.; Kim, B.H.; Lee, J.S.; Ryu, J.K.; Kim, Y.T. Fisetin Reduces Cell Viability Through Up-Regulation of Phosphorylation of ERK1/2 in Cholangiocarcinoma Cells. Anticancer Res. 2016, 36, 6109–6116. [CrossRef] [PubMed]
7. Kang, K.A.; Piao, M.J.; Hewage, S.R.M.; Ryu, Y.S.; Oh, M.C.; Kwon, T.K.; Chae, S.; Hyun, J.W. Fisetin induces apoptosis and endoplasmic reticulum stress in human non-small cell lung cancer through inhibition of the MAPK signaling pathway. Tumour Biol. 2016, 37, 9615–9624. [CrossRef] [PubMed]
8. Su, C.H.; Kuo, C.L.; Lu, K.W.; Yu, F.S.; Ma, Y.S.; Yang, J.L.; Chu, Y.L.; Chueh, F.S.; Liu, K.C.; Chung, J.G. Fisetin-induced apoptosis of human oral cancer SCC-4 cells through reactive oxygen species production, endoplasmic reticulum stress, caspase-, and mitochondria-dependent signaling pathways. Environ. Toxicol. 2017, 32, 1725–1741. [CrossRef] [PubMed]
9. Mukhtar, E.; Adhami, V.M.; Siddiqui, I.A.; Verma, A.K.; Mukhtar, H. Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells. Mol. Cancer Ther. 2016, 15, 2863–2874. [CrossRef] [PubMed]
10. Szliszka, E.; Helewski, K.J.; Mizgala, E.; Krol, W. The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells. Int. J. Oncol. 2011, 39, 771–779. [PubMed]
11. Zou, W.; Liu, X.; Yue, P.; Zhou, Z.; Sporn, M.B.; Lotan, R.; Khuri, F.R.; Sun, S.Y. c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells. Cancer Res. 2004, 64, 7570–7578. [CrossRef] [PubMed]
12. Wu, G.S.; Burns, T.F.; McDonald, E.R., 3rd; Jiang, W.; Meng, R.; Krantz, I.D.; Kao, G.; Gan, D.D.; Zhou, J.Y.; Muschel, R.; et al. el-Deiry, KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet. 1997, 17, 141–143. [CrossRef] [PubMed]
13. Takimoto, R.; El-Deiry, W.S. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. Oncogene 2000, 19, 1735–1743. [CrossRef] [PubMed]
14. Yamaguchi, H.; Wang, H.G. CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J. Biol. Chem. 2004, 279, 45495–45502. [CrossRef] [PubMed]
15. Shetty, S.; Gladden, J.B.; Henson, E.S.; Hu, X.; Villanueva, J.; Haney, N.; Gibson, S.B. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines. Apoptosis 2002, 7, 413–420. [CrossRef] [PubMed]
16. Kojima, Y.; Nakayama, M.; Nishina, T.; Nakano, H.; Koyanagi, M.; Takeda, K.; Okumura, K.; Yagita, H. Importin beta1 protein-mediated nuclear localization of death receptor 5 (DR5) limits DR5/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced cell death of human tumor cells. J. Biol. Chem. 2011, 286, 43383–43393. [CrossRef] [PubMed]
17. Simova, S.; Klima, M.; Cermak, L.; Sourkova, V.; Andera, L. Arf and Rho GAP adapter protein ARAP1 participates in the mobilization of TRAIL-R1/DR4 to the plasma membrane. Apoptosis 2008, 13, 423–436. [CrossRef] [PubMed]
18. Jin, Z.; McDonald, E.R., 3rd; Dicker, D.T.; El-Deiry, W.S. Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis. J. Biol. Chem. 2004, 279, 35829–35839. [CrossRef] [PubMed]
19. Leithner, K.; Stacher, E.; Wurm, R.; Ploner, F.; Quehenberger, F.; Wohlkoenig, C.; Balint, Z.; Polachova, J.; Olschewski, A.; Samonigg, H.; et al. Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy. Lung Cancer 2009, 65, 98–104. [CrossRef] [PubMed]
20. Di, X.; Zhang, G.; Zhang, Y.; Takeda, K.; Rosado, L.A.R.; Zhang, B. Accumulation of autophagosomes in breast cancer cells induces TRAIL resistance through downregulation of surface expression of death receptors 4 and 5. Oncotarget 2013, 4, 1349–1364. [CrossRef] [PubMed]
21. Posadas, E.M.; Limvorasak, S.; Figlin, R.A. Targeted therapies for renal cell carcinoma. Nat. Rev. Nephrol. 2017, 13, 496–511. [CrossRef] [PubMed]
22. Lim, D.Y.; Park, J.H. Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296, G1060–G1068. [CrossRef] [PubMed]
23. Tomasetti, M.; Andera, L.; Alleva, R.; Borghi, B.; Neuzil, J.; Procopio, A. Alpha-tocopheryl succinate induces DR4 and DR5 expression by a p53-dependent route: Implication for sensitisation of resistant cancer cells to TRAIL apoptosis. FEBS Lett. 2006, 580, 1925–1931. [CrossRef] [PubMed]
24. Jang, K.Y.; Jeong, S.J.; Kim, S.H.; Jung, J.H.; Kim, J.H.; Koh, W.; Chen, C.Y.; Kim, S.H. Activation of reactive oxygen species/AMP activated protein kinase signaling mediates fisetin-induced apoptosis in multiple myeloma U266 cells. Cancer Lett. 2012, 319, 197–202. [CrossRef] [PubMed]
25. Ying, T.H.; Yang, S.F.; Tsai, S.J.; Hsieh, S.C.; Huang, Y.C.; Bau, D.T.; Hsieh, Y.H. Fisetin induces apoptosis in human cervical cancer HeLa cells through ERK1/2-mediated activation of caspase-8-/caspase-3-dependent pathway. Arch. Toxicol. 2012, 86, 263–273. [CrossRef] [PubMed]
26. Suh, Y.; Afaq, F.; Johnson, J.J.; Mukhtar, H. A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways. Carcinogenesis 2009, 30, 300–307. [CrossRef] [PubMed]
27. Li, J.; Cheng, Y.; Qu, W.; Sun, Y.; Wang, Z.; Wang, H.; Tian, B. Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells. Basic Clin. Pharmacol. Toxicol. 2011, 108, 84–93. [CrossRef] [PubMed]
28. Wu, M.S.; Lien, G.S.; Shen, S.C.; Yang, L.Y.; Chen, Y.C. N-acetyl-L-cysteine enhances fisetin-induced cytotoxicity via induction of ROS-independent apoptosis in human colonic cancer cells. Mol. Carcinog. 2014, 53 (Suppl. 1), E119–E129. [CrossRef] [PubMed]
29. Cazanave, S.C.; Mott, J.L.; Bronk, S.F.; Werneburg, N.W.; Fingas, C.D.; Meng, X.W.; Finnberg, N.; El-Deiry, W.S.; Kaufmann, S.H.; Gores, G.J. Death receptor 5 signaling promotes hepatocyte lipoapoptosis. J. Biol. Chem. 2011, 286, 39336–39348. [CrossRef] [PubMed]
30. Lu, M.; Lawrence, D.A.; Marsters, S.; Acosta-Alvear, D.; Kimmig, P.; Mendez, A.S.; Paton, A.W.; Paton, J.C.; Walter, P.; Ashkenazi, A. Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis. Science 2014, 345, 98–101. [CrossRef] [PubMed]
31. Lim, S.C.; Duong, H.Q.; Choi, J.E.; Lee, T.B.; Kang, J.H.; Oh, S.H.; Han, S.I. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells. Carcinogenesis 2011, 32, 723–731. [CrossRef] [PubMed]
32. Dilshara, M.G.; Kang, C.H.; Choi, Y.H.; Kim, G.Y. Mangiferin inhibits tumor necrosis factor-alpha-induced matrix metalloproteinase-9 expression and cellular invasion by suppressing nuclear factor-kappaB activity. BMB Rep. 2015, 48, 559–564. [CrossRef] [PubMed]
33. An, Y.A.; Hwang, J.Y.; Lee, J.S.; Kim, Y.C. Cornus officinalis Methanol Extract Upregulates Melanogenesis in Melan-a Cells. Toxicol. Res. 2015, 31, 165–172. [CrossRef] [PubMed]